The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative ...
FDA to offer bonuses for faster, high-quality drug reviews to boost efficiency and retain staff, sparking debate over speed versus safety standards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results